Stratos Wealth Advisors LLC Has $704,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Stratos Wealth Advisors LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 4.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,828 shares of the company’s stock after selling 373 shares during the quarter. Stratos Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $704,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 0.6% during the 1st quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock valued at $1,309,583,000 after acquiring an additional 112,177 shares in the last quarter. Morgan Stanley increased its position in Colgate-Palmolive by 3.2% in the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock worth $1,195,785,000 after purchasing an additional 514,559 shares during the last quarter. Moneta Group Investment Advisors LLC raised its stake in shares of Colgate-Palmolive by 90,253.2% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock worth $1,258,627,000 after purchasing an additional 15,956,771 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Colgate-Palmolive by 0.5% during the 1st quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock valued at $793,971,000 after buying an additional 50,040 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $644,715,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on CL. UBS Group lifted their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Wells Fargo & Company increased their target price on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research report on Thursday, January 18th. StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Finally, Morgan Stanley upped their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $87.31.

Insider Buying and Selling at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the sale, the insider now owns 57,948 shares in the company, valued at approximately $4,863,575.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the transaction, the director now owns 19,272 shares in the company, valued at $1,628,484. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock worth $19,505,099 over the last three months. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 0.5 %

Shares of CL stock opened at $87.88 on Monday. The stock has a market cap of $72.24 billion, a P/E ratio of 31.61, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The stock has a fifty day moving average price of $86.61 and a 200 day moving average price of $79.86. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.77 earnings per share. Analysts predict that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a $0.50 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s payout ratio is currently 69.06%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.